glp-1 diarrhea and vomiting Why Semaglutide Causes Diarrhea: Understanding Effects on Gut Motility & Digestion GLP-1 Intolerance and Endoscopic Sleeve

Empagliflozin is associated with improvements in liver enzymes potentially consistent with reductions in liver fat: results from randomised trials including the EMPA-REG OUTCOME trial

patent expires in 2032.

Lan T, Morgan DA, Rahmouni K et al (2017) FGF19, FGF21, and an FGFR1/beta-Klotho-Activating Antibody Act on the Nervous System to Regulate Body Weight and Glycemia

Theres a great risk of muscle loss and malnutrition They can interfere with the absorption of other meds, including psychiatric meds Some people wont lose any weight at all Most people will regain weight after they discontinue use (as is the case with any diet) Theres limited long term research and a whole bunch of misinformation They can alter taste perception and decrease the enjoyment of eating So we know they can help with diabetes, theres a long list of risks and more we dont know, and at the same time some people have found GLP-1s offer the potential to re-connect with internal signals and eventually help build body trust

The Precision Peptide Genetic Test examines variants in GLP1R, GIPR, FTO, and MC4R genes that may influence peptide-pathway sensitivity

Part of that drop is straightforward physics: a smaller body burns fewer calories simply because there is less tissue to maintain